Belli Maria Luisa, Fiorino Claudio, Zerbetto Flavia, Raso Roberta, Broggi Sara, Chiara Anna, Cattaneo Giovanni Mauro, Di Muzio Nadia, Dell'oca Italo, Calandrino Riccardo
a Medical Physics, S. Raffaele Scientific Institute , Milano , Italy.
b Radiotherapy, S. Raffaele Scientific Institute , Milano , Italy.
Acta Oncol. 2015;54(9):1490-5. doi: 10.3109/0284186X.2015.1062137. Epub 2015 Jul 23.
We investigated the possibility to early identify non-responding patients based on FDG-PET positive lymph nodes (PNs) volume variation assessed with in-room images.
Twenty-seven head and neck cancer patients with at least one pre-treatment PNs were retrospectively analyzed; they received 54 Gy, 66 Gy, 69 Gy in 30 fractions on precautionary lymph nodal (N), primary (T) and PET positive (BTV) planning target volumes (PTVs), respectively with Helical TomoTherapy (SIB approach). PNs volume changes during treatment were assessed based on megavoltage computed tomography (MVCT) used for image guidance as ratio between volumes at fractions 10/20/30 and at first fraction. Data on T, N and M relapses (rT, rN, rM) were collected for all patients. The difference of PNs volume changes, during treatment, between patients with versus without relapses was tested (Mann-Whitney test). The impact of shrinkage on the corresponding survival curves (Cox proportional-hazard regression), dividing between no/moderate versus large shrinkage (based on ROC curve best cut-off value) was also investigated.
Median follow-up was 27.4 m (3.7-108.9). The numbers for rT, rN, rM were 5, 4, 6, respectively. Differences in PNs shrinkage were found between patients with and without rT/rN at all considered timing [fr 20, rT: 0.56 vs. 1.07 (median), p = 0.06; rN: 0.57 vs. 1.25, p = 0.07]. Differences were lower for rM. Survival curves provide high hazard ratios (HR) between PNs changes and rT/rN at all considered timing [fr 20, rT: best cut-off = 0.58, HR 5.1 (95% CI 0.5-49.4), p = 0.12; rN: best cut-off = 0.98, HR 14.9 (1.6-142.9), p = 0.01].
A limited shrinkage of PNs during treatment is associated with poorer outcome in terms of T/N relapses. The early variation of PNs observed on in-room images may provide useful information about the individual response with potential application in guiding an early adaptation of the treatment.
我们研究了基于室内图像评估的氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)阳性淋巴结(PNs)体积变化早期识别无反应患者的可能性。
对27例至少有一个治疗前PNs的头颈癌患者进行回顾性分析;他们分别采用螺旋断层放疗(同步整合推量[SIB]方法)在预防性淋巴结(N)、原发灶(T)和PET阳性(BTV)计划靶体积(PTV)上接受30次分割的54 Gy、66 Gy、69 Gy照射。基于用于图像引导的兆伏级计算机断层扫描(MVCT),将第10/20/30分次时的体积与第一次分次时的体积之比作为评估治疗期间PNs体积变化的数据。收集所有患者的T、N和M复发(rT、rN、rM)数据。对有复发和无复发患者治疗期间PNs体积变化的差异进行检验(曼-惠特尼检验)。还研究了缩小程度对相应生存曲线的影响(Cox比例风险回归),根据受试者工作特征曲线(ROC曲线)最佳截断值分为无/中度缩小与大幅缩小。
中位随访时间为27.4个月(3.7 - 108.9个月)。rT、rN、rM的例数分别为5、4、6。在所有考虑的时间点,有和无rT/rN的患者之间PNs缩小存在差异[第20分次时,rT:0.56对1.07(中位数),p = 0.06;rN:0.57对1.25,p = 0.07]。rM的差异较小。生存曲线显示在所有考虑的时间点PNs变化与rT/rN之间存在高风险比(HR)[第20分次时,rT:最佳截断值 = 0.58,HR 5.1(95%CI 0.5 - 49.4),p = 0.12;rN:最佳截断值 = 0.98,HR 14.9(1.6 - 142.9),p = 0.01]。
治疗期间PNs缩小有限与T/N复发方面的较差预后相关。在室内图像上观察到的PNs早期变化可能提供有关个体反应的有用信息,在指导治疗的早期调整方面具有潜在应用价值。